NDC 0026-9711 - Viadur
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0026-9711
- Package NDCs from labels
- 0026-9711-01
- Manufacturer
- Bayer Pharmaceuticals Corporation
- Effective date
- 2006-05-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Viadur - Bayer Pharmaceuticals Corporation | Bayer Pharmaceuticals Corporation | 2006-05-10 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0026-9711-01 | Viadur | 1 in 1 BOX | KIT | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Eugia US LLC | ef782e5e-e2d7-465a-99c6-b12611f3158c | 2024-09-12 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Lifestar Pharma LLC | 9cb98fb0-5204-4973-8be7-f44ddbfde2ab | 2024-09-03 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Asclemed USA, Inc. | 45416533-17a1-4757-b24e-b33d1ee57471 | 2024-06-20 | Warnings, Adverse reactions | 1010671 |
| 2% LIDOCAINE HCI | 2% LIDOCAINE HCI | HF Acquisition Co LLC, DBA HealthFirst | 78d8fb0a-bfae-6599-e053-2991aa0a2e03 | 2024-01-28 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 8968c61e-2686-0fe6-e053-2a95a90a15fa | 2023-05-23 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 858f3faa-e56e-51f9-e053-2a91aa0aa721 | 2023-05-23 | Warnings, Adverse reactions | 1010671 |
| Lidocaine | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 86083fea-c064-4ef7-e053-2a91aa0ac17c | 2023-05-16 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | b63614eb-8776-4cd0-e053-2995a90a8f82 | 2023-05-04 | Warnings, Adverse reactions | 1010671 |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | c8e8b217-a183-0d91-e053-2a95a90a4a44 | 2023-04-25 | Warnings, Adverse reactions | 1010671 |
| Xylocaine | LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE | Fresenius Kabi USA, LLC | ba082c2f-64f4-419d-9c88-74f203316e17 | 2021-08-25 | Warnings, Adverse reactions | 1010671 |
| D241F634-1434-3A77-5788-54CF4BAD5673 | 82c5998f-2253-4880-9be5-feaba553d5d1 | 2006-05-10 | Warnings, Adverse reactions | D241F634-1434-3A77-5788-54CF4BAD5673 82c5998f-2253-4880-9be5-feaba553d5d1 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.